Psoriatic Patients with Cancer: A Multicentric Real-Life Study Comparing Risankizumab and Apremilast
Dermatology · 05.08.2026 · 1-6
DOI: 10.1159/000553458 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatology, online erschienen am 05.08.2026. Verfasst von Annunziata Raimondo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Surgery and Dentistry, "Scuola Medica Salernitana", University of Salerno, Salerno, Italy, araimondo@unisa.it. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Introduction: Evidence on the management of psoriasis in patients with a recent history of malignancy is limited, and safety data on systemic and biologic therapies in this setting are very important. Recent studies confirm the safety of anti-interleukin (IL) biological drugs in patients with psoriasis and a personal history of cancer. This report presents the safety and effectiveness assessments of risankizumab (RISA) and apremilast (APRE) in psoriatic patients with a recent cancer diagnosis (
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Surgery and Dentistry, "Scuola Medica Salernitana", University of Salerno, Salerno, Italy, araimondo@unisa.it.
- Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.
- Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Section of Dermatology, University of Messina, Messina, Italy.
- Dermatology Unit, San Giovanni di Dio e Ruggi D'Aragona University Hospital, Salerno, Italy.
- Dermatology Unit, A. Tortora Hospital, Pagani, Italy.
- Section of Dermatology, Department of Clinical, Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Zitieren
APA
Raimondo, A., Balato, A., Guarneri, C., Ligrone, L., Manzo, R., Megna, M., Musumeci, M. L., Palazzo, G., Puca, R. V., Romano, F., & Lembo, S. (2026). Psoriatic Patients with Cancer: A Multicentric Real-Life Study Comparing Risankizumab and Apremilast. Dermatology, 1-6. https://doi.org/10.1159/000553458
Vancouver
Raimondo A, Balato A, Guarneri C, Ligrone L, Manzo R, Megna M, et al. Psoriatic Patients with Cancer: A Multicentric Real-Life Study Comparing Risankizumab and Apremilast. Dermatology. 2026:1-6. doi:10.1159/000553458
BibTeX
@article{Raimondo2026,
author = {Raimondo, Annunziata and Balato, Anna and Guarneri, Claudio and Ligrone, Luigi and Manzo, Raffaella and Megna, Matteo and Musumeci, Maria Letizia and Palazzo, Giovanni and Puca, Rosa Valentina and Romano, Francesca and Lembo, Serena},
title = {Psoriatic Patients with Cancer: A Multicentric Real-Life Study Comparing Risankizumab and Apremilast},
journal = {Dermatology},
year = {2026},
pages = {1--6},
doi = {10.1159/000553458}
}
EUVIMED